US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

63.34

+0.94191.51%

Volume:22.05K

Turnover:1.40M

Market Cap:273.63M

PE:20.72

High:63.75

Open:63.03

Low:63.03

Close:62.40

52wk High:64.10

52wk Low:39.10

Shares:4.32M

Float Shares:4.32M

Volume Ratio:0.74

T/O Rate:0.51%

Dividend:1.53

Dividend Rate:2.41%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guardant Health price target raised to $190 from $160 at Guggenheim

Revolution Medicines Inc : JP Morgan Raises Target Price to $205 from $200

THOMSON REUTERS

Space and Defense Co Karman Climbs on S&P Smallcap Addition

Axsome Says FDA Accepts Axs-12 Narcolepsy Cataplexy NDA, Sets May 1, 2027 PDUFA Date

Axsome Therapeutics - FDA Sets Pdufa Target Action Date of May 1, 2027 for Axs-12 Nda

THOMSON REUTERS

Axsome Therapeutics - FDA Does not Plan Advisory Committee Meeting for Axs-12 Nda

THOMSON REUTERS

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for Axs-12 for the Treatment of Cataplexy in Narcolepsy

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)

BrightSpring Health Services Set to Join S&P MidCap 400 Index

MT Newswires Live

BrightSpring Health to replace Chart Industries in S&P 400 at open on 7/17

S&P Dow Jones Indices: Brightspring Health Services to Replace Chart Industries in S&P Midcap 400

THOMSON REUTERS

S&P Dow Jones Indices: Karman Holdings to Replace Brightspring Health Services in S&P Smallcap 600

THOMSON REUTERS

Is Axsome Therapeutics (AXSM) Reframing Its CNS Strategy With Pediatric Solriamfetol Trial Expansion?

Simply Wall St.

Brightspring Health Svcs is Maintained at Overweight by Morgan Stanley

Guardant Health is Maintained at Buy by Canaccord Genuity

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Axsome Therapeutics (AXSM) and Nurix Therapeutics (NRIX)

Axsome Therapeutics to Report Q2 Financial Results, Host Conference Call

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

Guardant Health price target raised to $205 from $135 at Canaccord

BrightSpring Health price target raised to $80 from $60 at KeyBanc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PTH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":63.34,"timestamp":1787685537951,"preClose":62.3981,"halted":0,"volume":22051,"delay":0,"changeRate":0.015095010905780849,"floatShares":4320000,"shares":4320000,"eps":3.057033,"marketStatus":"Trading","change":0.9419,"latestTime":"08-25 15:23:34 EDT","open":63.03,"high":63.75,"low":63.03,"amount":1401677.504158,"amplitude":0.011539,"askPrice":63.36,"askSize":300,"bidPrice":63.25,"bidSize":291,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.3981,"sharesOutstanding":2480000,"nav":62.98271,"aum":273974788.5,"dividendRate":0.024136,"bidAskSpread":0.002049,"postHourTrading":{"tag":"盘后","latestPrice":62.41,"preClose":62.3981,"latestTime":"19:30 EDT","volume":14,"amount":872.8867,"timestamp":1787614203296,"change":0.0119,"changeRate":0.000191,"amplitude":0},"volumeRatio":0.738489,"impliedVol":0.1608,"impliedVolPercentile":0.7928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.738489,"shares":4320000,"dividePrice":1.5288,"high":63.75,"amplitude":0.011539,"preClose":62.3981,"low":63.03,"week52Low":39.1,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":63.34,"committee":-0.015228,"eps":3.057033,"divideRate":0.024136,"volume":22051,"delay":0,"ttmEps":3.057033,"open":63.03,"prevYearClose":49.701,"prevWeekClose":62.9761,"prevMonthClose":58.0963,"prevQuarterClose":59.76,"fiveDayClose":60.7585,"twentyDayClose":57.983,"sixtyDayClose":51.9608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651344620","title":"Guardant Health price target raised to $190 from $160 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651344620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651344620?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199651,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Guardant Health (GH) to $190 from $160 and keeps a Buy rating on the shares. The firm says its Q2 web ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","BK4535","GDOC","BK4588","GH","LFSC","LU0109394709.USD","EKG","BK4585","BK4551","GNOM","PTH","BK4196","LU0889565916.HKD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410809","title":"Revolution Medicines Inc : JP Morgan Raises Target Price to $205 from $200","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651410809?lang=en_us&edition=fundamental","pubTime":"2026-07-16 17:04","pubTimestamp":1784192680,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I0XC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","IE00BJJMRZ35.SGD","PTH","IE0009355771.USD","IE0009354923.USD","BBH","IE00BJT1NW94.SGD","LU0109394709.USD","CANC","IE00BFTCPJ56.SGD","RVMD","BK4139","IDNA","LU0889565916.HKD","IE00B2B36J28.USD","IE0002141913.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450415","title":"Space and Defense Co Karman Climbs on S&P Smallcap Addition","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450415","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651450415?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:49","pubTimestamp":1784116156,"startTime":"0","endTime":"0","summary":"BUZZ-Space and defense co Karman climbs on S&P SmallCap addition** Shares of space and defense systems maker Karman HoldingsKRMN.Nup 4.3% to $47.82 before the bell on Weds as it's set to join S&P SmallCap 600 index.SPCY** KRMN to replace BrightSpring Health ServicesBTSG.Oin SPCY effective Fri, Jul 17, S&P Dow Jones Indices announced late Tues** BTSG migrating to S&P MidCap 400 index.IDXand will replace Chart IndustriesGTLS.N, which is beingacquiredby oilfield services firm Baker HughesBKR.Oin$13.6 bln dealannounced a year ago** BTSG shares down 0.8% in thin trading premarket** Stephens analyst Melissa Roberts said in a note she expects passive funds will need to buy 12.3 mln KRMN shares, implying about 4 days of purchasing demand** Huntington Beach, California-based KRMN has ~132.5 mln shares outstanding for $6 bln market cap** At Tues close, KRMN stock down 37% YTD** 10 of 11 analysts rate the stock \"strong buy\" or \"buy\", 1 recommends \"sell\"; median PT $107, per LSEG data","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL6N43H0P7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","SG9999014880.SGD","LU0354030511.USD","LU0154245673.USD","LU2089284900.SGD","BK4597","GTLS","BK4548","LU2089283258.USD","LU2764263203.CNY","IE00BFMHRM44.USD","FDIQ","LU0097036916.USD","SGXZ31699556.SGD","IAI","PXJ","BK4566","IE00B19Z9505.USD","LU1084165304.USD","BKR","LU1633808545.USD","KRMN","LU2468319806.SGD","SG9999018857.SGD","SPGI","LU1119994496.HKD","SG9999018865.SGD","LU2210150020.SGD","BK4196","LU2111349929.HKD","LU0158827948.USD","LU1496350171.SGD","SG9999014914.USD","LU1989764664.SGD","LU2249611893.SGD","PTH","PSCH","IE0002270589.USD","LU2506951958.HKD","LU0868494617.USD","LU2355687059.USD","LU0342679015.USD","LU0971096721.USD","OIH","IEZ","BK4588","BTSG","LU1989773731.SGD","LU2048586759.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651520414","title":"Axsome Says FDA Accepts Axs-12 Narcolepsy Cataplexy NDA, Sets May 1, 2027 PDUFA Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2651520414","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651520414?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:02","pubTimestamp":1784113322,"startTime":"0","endTime":"0","summary":"Axsome says FDA accepts AXS-12 narcolepsy cataplexy NDA, sets May 1, 2027 PDUFA dateAxsome Therapeutics’ NDA for AXS-12 (reboxetine) to treat cataplexy in narcolepsy was accepted for FDA review.The FD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL32qQ09:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","PTH","BK4007","LU2210149790.SGD","LU2210150020.SGD","LU2095319765.USD","AXSM","BK4505","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","NDAQ","BK4585","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014039.USD","BCDF","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651545227","title":"Axsome Therapeutics - FDA Sets Pdufa Target Action Date of May 1, 2027 for Axs-12 Nda","url":"https://stock-news.laohu8.com/highlight/detail?id=2651545227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651545227?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA3CXY7H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","BK4007","BK4505","AXSM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651452222","title":"Axsome Therapeutics - FDA Does not Plan Advisory Committee Meeting for Axs-12 Nda","url":"https://stock-news.laohu8.com/highlight/detail?id=2651452222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651452222?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA3CXY7H:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","AXSM","BK4007","PTH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651273452","title":"Axsome Therapeutics Announces FDA Acceptance of New Drug Application for Axs-12 for the Treatment of Cataplexy in Narcolepsy","url":"https://stock-news.laohu8.com/highlight/detail?id=2651273452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651273452?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:00","pubTimestamp":1784113201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA3CXY7H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4007","AXSM","PTH","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651452589","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651452589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651452589?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:40","pubTimestamp":1784112028,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company (MRK), Annexon Biosciences (ANNX) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-annexon-biosciences-annx-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-annexon-biosciences-annx-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","BK4139","LU1934455194.USD","IE00BLSP4452.SGD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD","LU2089984988.USD","ANNX","LU0006306889.USD","SG9999001440.SGD","LU0130102774.USD","LU1093756325.SGD","HELX","LU1057294990.SGD","FHLC","LU0861579265.USD","LU2125909247.SGD","LU0965508806.USD","LU1116320737.USD","LU2361044865.SGD","SG9999014559.SGD","IE00BJT1NW94.SGD","LU2023250843.SGD","LU1974910355.USD","LU0942090050.USD","LU0965509010.AUD","LU2491050071.SGD","LU0266013472.USD","GNOM","LU0203347892.USD","LU0211331839.USD","LU0648001328.SGD","LU2360032135.SGD","LU0106261372.USD","LU1929549753.HKD","IE0002141913.USD","BK4516","LU0265550946.USD","LU1035773651.USD","BK4588","EKG","SG9999014567.USD","LU1941712264.USD","LU0477156953.USD","LU1585245621.USD","LU1061106388.HKD","BK4551","BK4533","GDOC","BK4550","PPH","IE00BJJMRZ35.SGD","LU0238689110.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1066053197.SGD","LU1989771016.USD","LU2468319806.SGD","LU1917777945.USD","LU1066051498.USD","LU1162221912.USD","LU0868494708.USD","SG9999013999.USD","LU1989772923.USD","LU2361044949.HKD","PAWZ","LU0859254822.USD","IE00B2B36J28.USD","BK4534","SG9999002232.USD","LU2106854487.HKD","LU1989772840.SGD","BK4585","BMED","LU2461242641.AUD","BK4196","IHE","LU0208291251.USD","LU0234572021.USD","LU0122379950.USD","LU2125909593.SGD","LU1201861249.SGD","IE0009355771.USD","LU1023059063.AUD","LU2361045086.USD","LU1934455277.USD","LU0098860793.USD","RXL","IE00BSNM7G36.USD","LU0320765646.SGD","SG9999014575.USD","LU2112291526.USD","LU1069347547.HKD","LU2491049909.HKD","LU0320765992.SGD","LU1571399168.USD","LU0289739699.SGD","IXJ","LU1941712348.USD","LU0965509283.SGD","LU0868494617.USD","LU0265550359.USD","LU0985320562.USD","JDOC","FTXH","LU1037948897.HKD","HRTS","LU1430594728.SGD","SG9999015341.SGD","LU0124676726.USD","BK4007","LU0058720904.USD","LU0070302665.USD","LU0130517989.USD","LU1923622614.USD","LU0965509101.SGD","LU2125154935.USD","SG9999015358.SGD","PTH","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","LU0109394709.USD","LU1291159041.SGD","LU2491050154.USD","SG9999001176.USD","LFSC","LU1934455863.HKD","LU0203345920.USD","LU2324357040.USD","LU2023250504.SGD","LU1699723380.USD","LU1983299246.USD","LU1116320901.HKD","IE00BBT3K403.USD","LU2433249047.HKD","LU2125154778.USD","BK4535","LU0689626769.HKD","SG9999001176.SGD","LU0320765489.SGD","VHT","LU1066051225.USD","BK4559","IYH","LU1066051811.HKD","LU2357627491.SGD","MRK","LU0889565916.HKD","GH","IE00BN8TJ469.HKD","SG9999014542.SGD","LU0432979614.USD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484683","title":"BrightSpring Health Services Set to Join S&P MidCap 400 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484683?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:40","pubTimestamp":1784065219,"startTime":"0","endTime":"0","summary":"BrightSpring Health Services  will join the S&P MidCap 400 index on July 17, the S&P Dow Jones Indices said in a late Tuesday statement.The company will replace Chart Industries , which is being acquired by Baker Hughes  in a deal expected to close on Thursday, according to the statement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PXJ","LU2468319806.SGD","UMDD","XMVM","SMDD","LU1261432733.SGD","IJH","LU0154245756.USD","MZZ","LU1084165304.USD","LU1988902786.USD","IEZ","PSCH","BK4585","IE00B7SZLL34.SGD","LU2264538146.SGD","LU1119994496.HKD","IE00B19Z3581.USD","XJH","IE00BFMHRM44.USD","MYY","OIH","IVOO","PTMC","MIDU","BK4588","SPMD","MDY","BTSG","BKR","LU0211331839.USD","PTH","IE00B7SZL793.SGD","LU1153585028.USD","LU2355687059.USD","RFG","GTLS","LU2089984988.USD","LU2023250504.SGD","BK4196","LU0011850046.USD","LU2211815571.USD","GRPM","LU0742534661.SGD","XMHQ","LU0048573561.USD","MVV","BK4161","LU0256331488.USD","QVMM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651657484","title":"BrightSpring Health to replace Chart Industries in S&P 400 at open on 7/17","url":"https://stock-news.laohu8.com/highlight/detail?id=2651657484","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651657484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:20","pubTimestamp":1784064018,"startTime":"0","endTime":"0","summary":"17:18 EDT BrightSpring Health (BTSG) to replace Chart Industries (GTLS) in S&P 400 at open on 7/17 Published first on TheFly – the ultimate source ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/brightspring-health-to-replace-chart-industries-in-sp-400-at-open-on-7-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/brightspring-health-to-replace-chart-industries-in-sp-400-at-open-on-7-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GTLS","LU2355687059.USD","IE00B66KJ199.SGD","PTH","LU2048586759.USD","BK4161","LU2468319806.SGD","IE0031619046.USD","LU0823414478.USD","BTSG","LU2249611893.SGD","PSCH","LU1064131342.USD","LU1988902786.USD","IE00BFMHRM44.USD","LU2089984988.USD","LU2211815571.USD","BK4196","IE00B7SZL793.SGD","IE00B19Z4B17.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651883484","title":"S&P Dow Jones Indices: Brightspring Health Services to Replace Chart Industries in S&P Midcap 400","url":"https://stock-news.laohu8.com/highlight/detail?id=2651883484","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651883484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:16","pubTimestamp":1784063812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G0WB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0031619046.USD","IE00B66KJ199.SGD","LU2249611893.SGD","IE00B7SZL793.SGD","PTH","IE00B19Z4B17.USD","LU2264538146.SGD","LU2468319806.SGD","IE00BFMHRM44.USD","LU2211815571.USD","LU0823414478.USD","KRMN","BTSG","LU1988902786.USD","LU1064131342.USD","LU2048586759.USD","LU2089984988.USD","PSCH","LU2355687059.USD","BK4187","GTLS","BK4196","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484886","title":"S&P Dow Jones Indices: Karman Holdings to Replace Brightspring Health Services in S&P Smallcap 600","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484886?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:16","pubTimestamp":1784063812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G0WB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFMHRM44.USD","LU2089984988.USD","BK4161","LU2355687059.USD","LU2468319806.SGD","GTLS","LU2264538146.SGD","BK4187","KRMN","IE0031619046.USD","BTSG","LU2211815571.USD","LU1988902786.USD","LU2048586759.USD","IE00B66KJ199.SGD","PTH","IE00B7SZL793.SGD","LU0823414478.USD","PSCH","LU1064131342.USD","IE00B19Z4B17.USD","BK4196","LU2249611893.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651910760","title":"Is Axsome Therapeutics (AXSM) Reframing Its CNS Strategy With Pediatric Solriamfetol Trial Expansion?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651910760","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651910760?lang=en_us&edition=fundamental","pubTime":"2026-07-14 22:26","pubTimestamp":1784039193,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics recently dosed the first patient in FOCUS-2, a Phase 3, randomized, double-blind, placebo-controlled trial evaluating solriamfetol in approximately 468 children aged 6 to under 12 with ADHD, measuring change in ADHD-RS-5 total score over 6 weeks.\nThis pediatric Phase 3 start, alongside an ongoing adolescent Phase 3 program, underscores Axsome’s push to broaden solriamfetol’s role across multiple CNS indications and age groups.\nWe’ll now examine how advancing solriamfetol...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/is-axsome-therapeutics-axsm-reframing-its-cns-strategy-with","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/is-axsome-therapeutics-axsm-reframing-its-cns-strategy-with","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CNS","PTH","BK4135","BK4007","BK4505","ABVC","BK4139","AXSM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651878106","title":"Brightspring Health Svcs is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2651878106","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651878106?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:53","pubTimestamp":1784033580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BTSG/analyst-ratings(END) Dow Jones NewswiresJuly 14, 2026 08:53 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","BK4196","PTH","LU2089984988.USD","LU2468319806.SGD","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651103511","title":"Guardant Health is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2651103511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651103511?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:05","pubTimestamp":1784030700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 14, 2026 08:05 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","EKG","HELX","GH","LFSC","GNOM","LU0320765992.SGD","BK4585","BK4551","BK4196","BK4535","GDOC","LU0889565916.HKD","LU0109394709.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651170999","title":"Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Axsome Therapeutics (AXSM) and Nurix Therapeutics (NRIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651170999","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651170999?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:20","pubTimestamp":1784028024,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Voyager Therapeutics (VYGR), Axsome Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-axsome-therapeutics-axsm-and-nurix-therapeutics-nrix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-axsome-therapeutics-axsm-and-nurix-therapeutics-nrix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4007","PTH","AXSM","VYGR","XLV","XBI","NRIX","BK4581","LU0029874061.USD","LU0128526141.USD","BK4137","LABU","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177980","title":"Axsome Therapeutics to Report Q2 Financial Results, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177980","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177980?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:00","pubTimestamp":1784026847,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics to report Q2 financial results, host conference callAxsome Therapeutics to report Q2 2026 financial results on Aug. 10, 2026, before the U.S. market open.Management conference call","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL7FVWTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","SG9999014005.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","BCDF","SG9999014013.SGD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","PTH","SG9999014039.USD","IE00B64PRP62.GBP","LU0314104364.USD","BK4112","IE00B3QW5Z07.USD","BK4007","NDAQ","AXSM","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651170658","title":"Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2651170658","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651170658?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:00","pubTimestamp":1784026800,"startTime":"0","endTime":"0","summary":"NEW YORK, July  14, 2026  (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/14/3326700/33090/en/Axsome-Therapeutics-to-Report-Second-Quarter-2026-Financial-Results-on-August-10.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","CNS","PTH","BK4007","AXSM","BK4135","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177472","title":"Guardant Health price target raised to $205 from $135 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177472?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:56","pubTimestamp":1784026600,"startTime":"0","endTime":"0","summary":"Canaccord analyst Kyle Mikson raised the firm’s price target on Guardant Health (GH) to $205 from $135 and keeps a Buy rating on the shares. The fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-205-from-135-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-205-from-135-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","EKG","BK4551","PTH","GH","LU0889565916.HKD","LU0109394709.USD","BK4585","BK4588","LU0320765992.SGD","BK4196","HELX","GNOM","BK4535","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651171252","title":"BrightSpring Health price target raised to $80 from $60 at KeyBanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2651171252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651171252?lang=en_us&edition=fundamental","pubTime":"2026-07-14 17:55","pubTimestamp":1784022938,"startTime":"0","endTime":"0","summary":"KeyBanc raised the firm’s price target on BrightSpring Health (BTSG) to $80 from $60 and keeps an Overweight rating on the shares. Healthcare utili...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/brightspring-health-price-target-raised-to-80-from-60-at-keybanc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/brightspring-health-price-target-raised-to-80-from-60-at-keybanc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","BK4196","XLV","PSCH","XBI","BTSG","BK4581","LABU","LU2089984988.USD","BK4585","LU2468319806.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}